Expected consequences of moving US pharma manufacturing to the US, by gender

Opinions on consequences in case U.S. pharma companies would be forced to manufacture in-country as of 2017, by gender

Expected consequences of moving US pharma manufacturing to the US, by gender This statistic shows the results of a survey conducted in the United States in February 2017, by gender. U.S. adults were given a list of 11 options and asked to select which consequences they would expect if U.S. pharma companies were forced to move their manufacturing from abroad back to the U.S. About 42 percent of female respondents said that they would expect higher drug prices, while 41 percent of male respondents indicated the same.
Show more

Opinions on consequences in case U.S. pharma companies would be forced to manufacture in-country as of 2017, by gender

Loading statistic...
Expand statistic
FemaleMale
Higher drug prices42%41%
Lower drug prices18%18%
Better quality of drugs21%23%
Better quality control31%33%
Fairer labor conditions20%19%
More jobs for US citizens48%44%
Decrease in manufacturing companies9%12%
Smaller range of available drugs14%15%
Other1%0%
Don't know14%13%
None of the above4%3%
FemaleMale
Higher drug prices42%41%
Lower drug prices18%18%
Better quality of drugs21%23%
Better quality control31%33%
Fairer labor conditions20%19%
More jobs for US citizens48%44%
Decrease in manufacturing companies9%12%
Smaller range of available drugs14%15%
Other1%0%
Don't know14%13%
None of the above4%3%
Download Settings Share
Download started
Please be patient - this may take a moment
This statistic shows the results of a survey conducted in the United States in February 2017, by gender. U.S. adults were given a list of 11 options and asked to select which consequences they would expect if U.S. pharma companies were forced to move their manufacturing from abroad back to the U.S. About 42 percent of female respondents said that they would expect higher drug prices, while 41 percent of male respondents indicated the same.
Show more
Statista Accounts: Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$49 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Leading companies trust Statista:
paypalgoogleadobepgsamsungtelekom
Statista is a great source of knowledge, and pretty helpful to manage the daily work.
Christof Baron

Christof Baron
CEO, MindShare Germany

Statistics on "Pharmaceutical industry in Norway "
  • Overview
The most important statistics
  • Production and trade
  • Pharmaceutical turnover
  • R&D, patents and new products
Discover Statista
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Learn more about how Statista can support your business.
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.